Wang Linlin, Ge Lihui, Zhang Guofeng, Wang Ziyi, Liu Yongyu, Ren Yi
Department of Thoracic Surgery, Shenyang Chest Hospital & Tenth People's Hospital, Shenyang, China.
Department of Health Management, Shengjing Hospital of China Medical University, Shenyang, China.
Front Surg. 2022 Aug 9;9:948026. doi: 10.3389/fsurg.2022.948026. eCollection 2022.
Prognostic factors in a pneumonectomy (PN) are not yet fully defined. This study sought to analyze and evaluate long-term survival after pneumonectomies (PNs) for patients with non-small cell lung cancer (NSCLC).
We obtained data from the Surveillance, Epidemiology, and End Results (SEER) database for patients who underwent PNs between 2004 and 2015. Propensity score matching (PSM) analysis and Kaplan-Meier curves were used to estimate overall survival (OS), while univariate and multivariable Cox proportional hazards regression analyses were applied to create a forest plot.
In total, 1,376 patients were grouped according to right/left PNs. Before matching, OS was worse after a right PN [hazard ratio (HR): 1.459; 95% CI 1.254-1.697; < 0.001] and after matching, survival differences between groups were not significant (HR: 1.060; 95% CI 0.906-1.240; = 0.465). Regression analysis revealed that age, gender, grade, lymph node dissection, N-stage, and chemotherapy were independent predictors of OS ( < 0.05). Chemotherapy was associated with improved OS ( < 0.001).
Laterality was not a significant prognostic factor for long-term survival after a PN for NSCLC. Chemotherapy was a significant independent predictor of improved OS. Long-term survival and outcomes analyses should be conducted on larger numbers of patients.
肺切除术(PN)的预后因素尚未完全明确。本研究旨在分析和评估非小细胞肺癌(NSCLC)患者肺切除术后的长期生存率。
我们从监测、流行病学和最终结果(SEER)数据库中获取了2004年至2015年间接受肺切除术患者的数据。采用倾向评分匹配(PSM)分析和Kaplan-Meier曲线来估计总生存期(OS),同时应用单变量和多变量Cox比例风险回归分析来绘制森林图。
总共1376例患者根据左右肺切除术进行分组。匹配前,右肺切除术后的总生存期较差[风险比(HR):1.459;95%置信区间1.254-1.697;P<0.001],匹配后,两组间的生存差异不显著(HR:1.060;95%置信区间0.906-1.240;P=0.465)。回归分析显示,年龄、性别、分级、淋巴结清扫、N分期和化疗是总生存期的独立预测因素(P<0.05)。化疗与总生存期的改善相关(P<0.001)。
对于NSCLC患者,肺切除术后的长期生存,手术侧别并非显著的预后因素。化疗是总生存期改善的显著独立预测因素。应针对更多患者进行长期生存和预后分析。